|Phone||00 44 (0)161 306 4220|
|VENTURE FUNDING TOTAL||$3.11M|
|Venture Round, 1/10 ||$403k|
|Venture Round, 1/12 ||£1.75M|
Ai2, Ltd. engages in the development of technology products to prevent infection on various commonly used medical devices. Its products include coated hydrogels for use in catheter, lens, and implant applications; artificial joints to prevent contamination and colonisation of orthopaedic implants by microbes; endotracheal tubes to protect endotracheal tubes from colonisation by microbes; wound dressings to confer anti-infective properties on wound dressing materials; urinary catheters to prevent colonisation by bacteria and other microbes; and vascular catheters. The companyâ€™s products are human protein-like substances to inhibit bacteria, fungi, and viruses on medical devices, such as urinary catheters, stents, and wound dressings. It serves healthcare companies in the United States and Europe. Ai2, Ltd. was founded in 2004 and is based in Manchester, the United Kingdom.